day 1 agenda
| Day-1 (June 24, 2024) | ||
| 08:30-09:00 | Registrations | |
| 9:00-09:10 | Welcome Remarks by Moderator | |
| Keynote Talks | ||
| Xiaojian Yao, University of Manitoba, Canada |
09:10-09:40 | Characterization of Recombinant Vesicular Stomatitis Virus rVSV-based Bivalent Vaccine Against SARS-CoV-2 and Influenza A Virus |
| Alderete, John F, Washington University, USA | 09:40-10:10 | Diagnostic targets and point-of-care serodiagnostic test for Trichomonas vaginalis, the most prevalent, non-viral sexually transmitted infection |
| Kunihiro Uryu, Janelia Reserch Campus, USA |
10:10-10:40 | Cellular topography and virus particle imaging by high-resolution SEM incorporated a freeze-drying and gaseous nitrogen-based approach |
| Group Photo & Refreshment Break (10:40-11:00) | ||
| Technical Session-I | ||
| Theme: New Vaccine Development Immunization |
||
| Session Chairs: Prof. Geetha Hitch | ||
| Alexandra R Lucas, Arizona State University (ASU), Biodesign Institute, USA | 11:00-11:20 | Virus-derived Serpin Targets Systemic Immune and Coagulation Disorders Improving Outcomes and Survival in Murine Models of Inflammatory Disease |
| Geeta Hitch, University of Sunderland in London, UK | 11:20-11:40 | Barriers to childhood immunization uptake in the countries in West Africa: A Systematic Literature Review |
| Guoping Liu, Yangtze University, China | 11:40-12:00 | C500 variants conveying complete mucosal immunity against fatal infections of pigs with Salmonella enterica serovar Choleraesuis C78-1 or F18+ Shiga toxin-producing Escherichia coli |
| Charles Jones, Pfizer, USA | 12:00-12:20 | Navigating the future adult vaccine landscape - innovation, an aging population and crowded schedules |
| Manisha Pandey, Griffith University, Australia | 12:20-12:40 | A Synthetic Peptide Vaccine Demonstrates Prophylactic and Therapeutic Efficacy Against Streptococcal Superficial and Invasive |
| Cecilia Ximénez, National University of Mexico, Mexico | 12:40-13:00 | Longitudinal anti-SARS-CoV-2antibody immune response in acute and convalescent patients |
| Lunch Break @ Restaurant (13:00-14:00) | ||
| Technical Session-II | ||
| Themes: Virology & Infectious Diseases | ||
| Session Chairs: Prof. Narcisa Mederle & Prof. Jun Tung | ||
| Miguel Ángel Cuesta-Geijo, INIA CSIC, Spain |
14:00-14:20 | Insights into the function of ESCRT complex and LBPA in ASFV infection |
| Narcisa Mederle, University of Life Sciences, Romania | 14:20-14:40 | First Identification of Trichinella pseudospiralis in a Golden Jackal (Canis aureus) in Romania |
| Wen-hai Feng, China Agricultural University, China | 14:40-15:00 | miR-204 suppresses porcine reproductive and respiratory syndrome virus (PRRSV) replication via inhibiting LC3B-mediated autophagy |
| Jun Tung, China Agricultural University, China | 15:00-15:20 | Alphaherpesvirus UHRF1 deficiency inhibits alphaherpesvirus through inducing RIG-I-IRF3-mediated interferon production |
| Uwe Staerz, Greffex, INC, USA | 15:20-15:40 | The Flexible, Versatile and Fast GreGT Platform of Fully Deleted Helper-Virus Independent Adenoviral Vectors |
| Victor Javier Cruz Holguin, Cinvestav, Mexico | 15:40-16:00 | Role of some antimicrobial peptides during ZIKA virus infection in keratinocyte cell line |
| Refreshment Break (16:00-16:10) | ||
| Filomena Fiorito, University of Naples Federico II, Italy | 16:10-16:30 | Potential antiviral action of funicone-like compounds towards canine coronavirus infection |
| 16:30-16:50 | Slot available | |
| 16:50-17:10 | Slot available | |
| Moses Silungwe Kapembwa, Imperial College of Medicine, United Kingdom | 17:10-17:30 | HIV enteropathy (HIVE) and ‘Slim disease’ (SD): historical and current perspectives |
| Panel Discussion | ||
day 2 agenda
| Day-2 (June 25, 2024) | ||
| Keynote Talks | ||
| Seth Lederman, TONIX Pharmaceuticals, Inc, USA | 09:00-09:30 | A new live virus, one-dose vaccine platform for Smallpox, Mpox, Covid-19 and other diseases of public health significance |
| Winfried Stöcker, Klin.med Lab, Germany | 09:30-10:00 | The Lübeck gene-free vaccination against Covid-19 |
| Devki Nandan, University of British Columbia, Canada | 10:00-10:30 | Leishmania targets host RNA interference machinery to promote its survival |
| Technical Session-III | ||
| Theme: COVID-19 & Influenza Vaccine research | ||
| Session Chairs: Dr. Manisha pandey | ||
| Wang Wei, Brigham and Women's Hospital, USA | 10:30-10:50 | Identify patterns and risk factors of post-COVID-19 vaccination side effects |
| Manisha singh, MDACC, USA | 10:50-11:10 | Enhancing Immunotherapy Efficacy and Reducing Toxicity in Pancreatic Cancer through IL-1 Pathway Blockade |
| Xiufen Zheng,Western University, London, Canada | 11:10-11:30 | The role of circular RNA in dendritic cells: a new target for robust dendritic cell vaccine |
| Refreshment Break (11:30-11:40) | ||
| Deok Ryun Kim, International Vaccine Institute, South Korea | 11:40-12:00 | Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines |
| Horacio Bach, University of British Columbia, Canada | 12:00-12:20 | Neutralization of SARS-CoV-2 by single-chain antibodies – a way to vaccine development |
| Rhea Coler, University of Washington/Seattle Children's Research Institute,USA | 12:20-12:40 | An RNA-based vaccine for tuberculosis |
| Robert N.J. Conradt, Conradt measurement and control technique, Germany | 12:40-13:00 | The dynamic reproduction index: precise determination from the incidence and insights based on new state diagrams |
| Lunch Break @ Restaurant (13:00-13:50) | ||
| Technical Session-IV | ||
| Theme: Infection, Immunity and Inflammation | ||
| Session Chairs: TBA | ||
| Elena Chaves Pozo, Instituto Español de Oceanografía (IEO), CSIC, Spain | 14:50-15:10 | Inheritance of maternally trained immunity in teleost fish |
| Dilruba Nasrin, University of Maryland Baltimore, USA | 15:10-15:30 | Enteropathogens associated with linear growth faltering in children in Africa and impact of antibiotic treatment |
| Balazs Sarkadi, RCNS Hungary - CelluVir Kft, Hungary | 15:30-15:50 | A new method for assessing antiviral cellular immunity by a microneedle skin patch |
| 15:50-16:10 | Slot available | |
| Umadevi Sajjan, Temple University, USA | 16:10-16:30 | Quercetin improves epithelial regeneration from COPD airway basal cells and innate immune function |
| Closing Ceremony | ||
| Day 2 Concludes | ||
| NOTE: This is Tentative program and subject to change | ||
| For more information, Contact @ stella_gibbons@infectious-diseases.org | ||
posters agenda
| Poster Presentations(13:50- 14:50) | ||
| Retsu Fujita, International University of Health and Welfare, Japan | P-1 | Longitudinal effects of direct observation of hand hygiene practices and monitoring of alcohol-based handrub consumption |
| Zhujun Ao, University of Manitoba, Canada | P-2 | Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses |
| Yuqing Liu, Yangtze University, China | P-3 | TBA |
| Luca Del Sorbo, University of Naples Federico II, Italy | P-4 | Antiviral activity of fungal secondary metabolites dummyagainst bovine coronavirus infection |
| Nada Madi, Kuwait University, Kuwait | P-5 | Genomic Characterization of Circulating Human Respiratory Syncytial Viruses A and B in Kuwait using whole-genome Sequencing |
| Patricia Morán, Universidad Nacional Autónoma De México, Mexico | P-6 | Seroconversion induced by vaccination against COVID-19 in Mexico City, Mexico |
| Liliana Rojas-Velàzquez, Universidad Nacional Autónoma De México, Mexico | P-7 | Symptoms caused by the SARS-Cov-2 virus in outpatients: an overview of different waves |
| Elchin Huseynov, Azerbaijan Medical University, Azerbaijan | P-8 | THE FEATURES OF ACUTE BRUCELLOSIS IN AZERBAIJAN REPUBLIC |
| Ewa Ostrycharz, University of Szczecin, Poland | P-9 | MicroRNAs participate in the regulation of apoptosis-related gene expression in rabbits infected with Lagovirus europaeus GI.1 and GI.2 genotypes |
Virtual
| Virtual Program | ||
| Day -2 (June 25, 2024, Tuesday) | ||
| Time Zone: Central European Time (CET) | ||
| Virtual Presentation Through ZOOM | ||
| Yaoli Wang, Daping Hospital, Army Medical University, China | 09:00-09:20 | Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai |
| Shiying Li, The second affiliated hospital of Chongqing Medical University, China | 09:20-09:40 | Bacterial co-infection raises in-hospital mortality of COVID-19 patients: a retrospective study |
| 09:40-10:00 | Slot available | |
| Olga Tarasova, Institute of Biomedical Chemistry, Russia | 10:00-10:20 | An analysis of virus-host interaction: case study for HIV-infection |
| Irina L Grigorova, Pirogov Russian National Research Medical University, Russia | 10:20-10:40 | Dual role of follicular regulatory T cells in the control of B cell response to vaccination |
| Rimas Jonas Jankunas, Lithuanian University of Health Sciences, Lithuania | 10:40-11:00 | Commentary on the impact of the COVID-19 passports in Lithuania |
| Tsvetelina Mandova, Gilson, France | 11:00-11:20 | Small molecules against arthropod-borne infectious diseases: A case study of acetylphloroglucinols from hops crops as potential therapeutics against Chikungunya |
| Oliver Charles Campbell White, Rowan Health Associates, United Kingdom | 11:20-11:40 | Corruption is making people sick |
| Stefan T Orszulik, United Kingdom | 11:40-12:00 | The quality of antimicrobial susceptibility test discs and implications for clinical outcomes |
| 12:00-12:20 | Slot available | |
| Javier León, University of Cantabria, Spain | 12:20-12:40 | MYC oncogene induces the expression of the Epstein-Barr virus receptor CR2/CD21 and stimulates the infection of Burkitt lymphoma cells |
| Carlos P. Dopazo, Universidade de Santiago de Compostela, Spain | 12:40-13:00 | Advantages of the digital PCR (dPCR) for detection and quantification of viruses |
| Abir Bouhamdi, Hassan II University Hospital, Morocco | 13:00-13:20 | Thirteen Cases of Pulmonary Pneumocystis in HIV-Negative Patients |
| Chaynez Rachid, chu mohammed VI , Morocco | 13:20-13:40 | Diagnostic Approach to Hypersensitivity Pneumonitis: A Report of Two Cases |
| Francisco Marlon Carneiro Feijo, UFERSA, Brazil | 13:40-14:00 | ANTIMICROBIAL POTENTIAL OF CREAMS BASED ON Phyllanthus niruri and Myracrodruon urundeuva IN POST-OVARIOHYSTERECTOMY WOUNDS in Felis catus |
| Chitra Upadhyay, Icahn School of Medicine at Mount Sinai, USA | 14:00-14:20 | Distinct mechanisms regulate the exposure of Broadly Neutralizing Antibody Epitopes on HIV-1 particles |
| Luke world, University of Florida, USA | 14:20-14:40 | Meta-analysis of direct endovascular thrombectomy vs bridging therapy in the management of acute ischemic stroke with large vessel occlusion |
| Pora Kim, The University of Texas Health Science Center at Houston, USA | 14:40-15:00 | FusionNeoAntigen: a resource of fusion gene-specific neoantigens |
| Lauren E. Dang, National Institute of Allergy and Infectious Diseases, USA | 15:00-15:20 | Causal frameworks for designing studies of immune correlates of risk for vaccine-preventable diseases: Start with the Target Trial Protocol, then follow the Roadmap for Causal Inference |
| Massimiliano Bissa, NCI/NIH, USA | 15:20-15:40 | Evaluation of the effect of ALFQA adjuvant on immunogenicity and efficacy of the V1-deleted DNA/ALVAC/gp120 anti-HIV vaccine candidate |
| Guoyun Chen, UTHSC, USA | 15:40-16:00 | Targeting Intracellular Neu1 for Coronavirus Infection Treatment |
| Ping Xie, Rutgers University, USA | 16:00-16:20 | The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansion |
| Lee Shapiro, University of Colorado Anschutz Medical Campus, USA | 16:20-16:40 | Strength and weakness revealed during research and clinical response to the COVID-19 pandemic |
| Alba Miranda Azola, Johns Hopkins University, USA | 16:40-17:00 | Clinical Approach to Fatigue in Long COVID: Implementing Lessons Learned from Myalgic Encephalomyelitis Chronic Fatigue Syndrome |
| 17:00-17:20 | Slot available | |
| Mari Numata-Nakamura, National Jewish Health, USA | 17:20-17:40 | Pulmonary Surfactant Lipids: Novel compounds as antivirals |
| Donald Arthur Berry, M.D. Anderson Cancer Center of the University of Texas, USA | 17:40-18:00 | Bayesian Analyses for Adaptive Clinical Trial Designs: Application to Lecanemab Phase 2b Dose-finding Trial in Alzheimer Disease |
| Evan Levy, Albert Einstein College of Medicine, USA | 18:00-18:20 | Tumor-targeted delivery of Tetanus toxoid by Listeria converts ovarian tumors from cold to hot |
| Hueiwang Anna Jeng, Old Dominion University, United states | 18:20-18:40 | Wastewater surveillance and copula time series modeling for monitoring COVID-19 cases and trends |
| Hira L. Nakhasi, U.S. Food and Drug Administration, USA | 18:40-19:00 | Advancement in Leishmania vaccination development and its role in global elimination of leishmaniasis |
| 19:00-19:20 | Slot available | |
| Day Concludes | ||
| NOTE: This is Tentative program and subject to change | ||
| Few Slots are available, To book your speaker slot, Please send an email @ stella_gibbons@infectious-diseases.org | ||